Latest Development News

Metals X finished the September quarter with A$434.87 million in cash, but Renison production and recovery fell while unit costs rose. The Rentails project’s engineering completion and final investment decision have also moved into the first half of calendar 2027.

Rumble Resources has outlined a preliminary A$86 million pre-tax NPV for Western Queen, with a 45% IRR and almost four years of planned underground production. The study also leaves room for tungsten upside, but financing, approvals and a feasibility study remain unresolved.

archTIS has reached a significant cash conversion milestone, with quarterly customer receipts exceeding operating payments for the first time since its Spirion acquisition. The cybersecurity company also reported higher margins, lower costs and fresh U.S. defence work, although its most closely watched enterprise licence remains unsigned.

Audeara has moved two AI noise reduction licensing programs into commercial production, helping lift quarterly revenue 37.7% while initial orders remain modest. The milestone arrives alongside A$247,000 in cash, a A$1.292 million operating outflow and a pending A$505,000 placement tranche.

Fortuna Metals has completed deeper drilling beneath its large inferred Mkanda rutile-graphite resource, returning broad mineralised intersections and a peak rutile grade of 3.43%. The company ended September with A$11.43 million in cash as it moves towards further resource definition and technical studies.

Sea Forest lifted first-quarter revenue 67% to A$3.4 million and generated a small operating cash inflow as it transitioned to a new distribution arrangement with Teys Australia. The agreement carries an indicative target of 480,000 cattle by June 2027, but the volume is not guaranteed and remains subject to implementation conditions.

Zinc of Ireland has reported average recoveries of 93% silver, 97% lead, 58% zinc and 80% copper from three zinc leach residue sources as it accelerates ARGO toward a pilot plant in early 2027. The company also completed an A$3.2 million placement, while critical-mineral recoveries and commercial-scale milestones remain outstanding.

Aurelia Metals generated its strongest quarterly Cobar operating cash flow since 2018 as higher gold, copper and zinc production lifted cash to A$160.7 million. The company reaffirmed FY27 guidance while moving closer to a major Peak processing expansion.

Ore Resources has converted its Miriam drilling campaign into a 153,200-ounce JORC Mineral Resource, with most ounces shallow and Forrest still open along strike and at depth. A separate conceptual Exploration Target points to a further 200,000 to 400,000 ounces, but remains unconverted exploration potential.

Southern Palladium’s Bengwenyama project has emerged from its latest study with a sharply higher forecast value, a 30-year mining right and a much larger chrome contribution. The development case is stronger, but the project still requires permits, external funding and further technical confirmation.

LTR Pharma has moved ROXUS from signed US commercial agreements to its first fulfilled patient-specific prescriptions, while SPONTAN’s final Phase II report completes the pharmacokinetic dataset agreed with the FDA. The company ended September with A$18.2 million in cash and no debt.

Amplia Therapeutics is preparing the next stage of narmafotinib’s pancreatic cancer development as its ACCENT trial nears completion and a Lilly collaboration broadens the drug’s potential into lung cancer. The biotech ended September with $20.8 million in cash, rising to $25.6 million pro forma after an October R&D tax refund.